<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35891354</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jun</Month><Day>23</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>HYGIEIA: HYpothesizing the Genesis of Infectious Diseases and Epidemics through an Integrated Systems Biology Approach.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1373</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v14071373</ELocationID><Abstract><AbstractText>More than two years on, the COVID-19 pandemic continues to wreak havoc around the world and has battle-tested the pandemic-situation responses of all major global governments. Two key areas of investigation that are still unclear are: the molecular mechanisms that lead to heterogenic patient outcomes, and the causes of Post COVID condition (AKA Long-COVID). In this paper, we introduce the HYGIEIA project, designed to respond to the enormous challenges of the COVID-19 pandemic through a multi-omic approach supported by network medicine. It is hoped that in addition to investigating COVID-19, the logistics deployed within this project will be applicable to other infectious agents, pandemic-type situations, and also other complex, non-infectious diseases. Here, we first look at previous research into COVID-19 in the context of the proteome, metabolome, transcriptome, microbiome, host genome, and viral genome. We then discuss a proposed methodology for a large-scale multi-omic longitudinal study to investigate the aforementioned biological strata through high-throughput sequencing (HTS) and mass-spectrometry (MS) technologies. Lastly, we discuss how a network medicine approach can be used to analyze the data and make meaningful discoveries, with the final aim being the translation of these discoveries into the clinics to improve patient care.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>Bradley</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-0778-0153</Identifier><AffiliationInfo><Affiliation>Integrated Pharmacometrics, Pharmacogenomics and Pharmacokinetics Group (PMGK), Louvain Drug Research Institute (LDRI), UCLouvain, Universit&#xe9; Catholique de Louvain, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Louvain Center for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Exp&#xe9;rimentale et Clinique (IREC), UCLouvain, Universit&#xe9; Catholique de Louvain, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yombi</LastName><ForeName>Jean Cyr</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Cliniques Universitaires Saint-Luc, UCLouvain, Universit&#xe9; Catholique de Louvain, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balligand</LastName><ForeName>Jean-Luc</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0002-0522-4156</Identifier><AffiliationInfo><Affiliation>WELBIO (Walloon Excellence in Life Sciences and Biotechnology), Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Experimentale et Clinique (IREC), Cliniques Universitaires Saint-Luc, UCLouvain, Universit&#xe9; Catholique de Louvain, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cani</LastName><ForeName>Patrice D</ForeName><Initials>PD</Initials><Identifier Source="ORCID">0000-0003-2040-2448</Identifier><AffiliationInfo><Affiliation>WELBIO (Walloon Excellence in Life Sciences and Biotechnology), Metabolism and Nutrition Research Group, Louvain Drug Research Institute (LDRI), UCLouvain, Universit&#xe9; Catholique de Louvain, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collet</LastName><ForeName>Jean-Fran&#xe7;ois</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>WELBIO (Walloon Excellence in Life Sciences and Biotechnology), de Duve Institute, UCLouvain, Universit&#xe9; Catholique de Louvain, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Greef</LastName><ForeName>Julien</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0200-1237</Identifier><AffiliationInfo><Affiliation>Louvain Center for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Exp&#xe9;rimentale et Clinique (IREC), UCLouvain, Universit&#xe9; Catholique de Louvain, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Cliniques Universitaires Saint-Luc, UCLouvain, Universit&#xe9; Catholique de Louvain, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dewulf</LastName><ForeName>Joseph P</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0001-7223-2706</Identifier><AffiliationInfo><Affiliation>Louvain Center for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Exp&#xe9;rimentale et Clinique (IREC), UCLouvain, Universit&#xe9; Catholique de Louvain, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Cliniques Universitaires Saint-Luc, UCLouvain, Universit&#xe9; Catholique de Louvain, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, de Duve Institute, UCLouvain, Universit&#xe9; Catholique de Louvain, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gatto</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-1520-2268</Identifier><AffiliationInfo><Affiliation>Computational Biology and Bioinformatics Unit (CBIO), de Duve Institute, UCLouvain, Universit&#xe9; Catholique de Louvain, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haufroid</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-5040-9806</Identifier><AffiliationInfo><Affiliation>Louvain Center for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Exp&#xe9;rimentale et Clinique (IREC), UCLouvain, Universit&#xe9; Catholique de Louvain, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Cliniques Universitaires Saint-Luc, UCLouvain, Universit&#xe9; Catholique de Louvain, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jodogne</LastName><ForeName>S&#xe9;bastien</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6685-7398</Identifier><AffiliationInfo><Affiliation>Computer Science and Engineering Department (INGI), Institute of Information and Communication Technologies, Electronics and Applied Mathematics (ICTEAM), UCLouvain, Universit&#xe9; Catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabamba</LastName><ForeName>Beno&#xee;t</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-0284-5210</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Cliniques Universitaires Saint-Luc, UCLouvain, Universit&#xe9; Catholique de Louvain, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>P&#xf4;le de Microbiologie, Institut de Recherche Exp&#xe9;rimentale et Clinique, UCLouvain, Universit&#xe9; Catholique de Louvain, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pyr Dit Ruys</LastName><ForeName>S&#xe9;bastien</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5449-1541</Identifier><AffiliationInfo><Affiliation>Integrated Pharmacometrics, Pharmacogenomics and Pharmacokinetics Group (PMGK), Louvain Drug Research Institute (LDRI), UCLouvain, Universit&#xe9; Catholique de Louvain, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vertommen</LastName><ForeName>Didier</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-7648-8282</Identifier><AffiliationInfo><Affiliation>De Duve Institute, and MASSPROT Platform, UCLouvain, Universit&#xe9; Catholique de Louvain, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elens</LastName><ForeName>Laure</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-0039-3583</Identifier><AffiliationInfo><Affiliation>Integrated Pharmacometrics, Pharmacogenomics and Pharmacokinetics Group (PMGK), Louvain Drug Research Institute (LDRI), UCLouvain, Universit&#xe9; Catholique de Louvain, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Louvain Center for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Exp&#xe9;rimentale et Clinique (IREC), UCLouvain, Universit&#xe9; Catholique de Louvain, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belkhir</LastName><ForeName>Le&#xef;la</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-1701-7584</Identifier><AffiliationInfo><Affiliation>Louvain Center for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Exp&#xe9;rimentale et Clinique (IREC), UCLouvain, Universit&#xe9; Catholique de Louvain, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Cliniques Universitaires Saint-Luc, UCLouvain, Universit&#xe9; Catholique de Louvain, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003141" MajorTopicYN="Y">Communicable Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055432" MajorTopicYN="N">Metabolomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049490" MajorTopicYN="N">Systems Biology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">genomics</Keyword><Keyword MajorTopicYN="N">metabolomics</Keyword><Keyword MajorTopicYN="N">metagenomics</Keyword><Keyword MajorTopicYN="N">network medicine</Keyword><Keyword MajorTopicYN="N">post COVID condition</Keyword><Keyword MajorTopicYN="N">proteomics</Keyword><Keyword MajorTopicYN="N">transcriptomics</Keyword></KeywordList><CoiStatement>PDC is co-founder A-Mansia SA and coinventor on patents dealing with gut microbes and health. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>1</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35891354</ArticleId><ArticleId IdType="pmc">PMC9318602</ArticleId><ArticleId IdType="doi">10.3390/v14071373</ArticleId><ArticleId IdType="pii">v14071373</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard.  [(accessed on 9 May 2022)].  Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>Sakurai A., Sasaki T., Kato S., Hayashi M., Tsuzuki S., Ishihara T., Iwata M., Morise Z., Doi Y. Natural History of Asymptomatic SARS-CoV-2 Infection. N. Engl. J. Med. 2020;383:885&#x2013;886. doi: 10.1056/NEJMc2013020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2013020</ArticleId><ArticleId IdType="pmc">PMC7304419</ArticleId><ArticleId IdType="pubmed">32530584</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortality Analyses&#x2014;Johns Hopkins Coronavirus Resource Center.  [(accessed on 6 May 2022)].  Available online:  https://coronavirus.jhu.edu/data/mortality.</Citation></Reference><Reference><Citation>Jeganathan N., Grewal S., Sathananthan M. Comparison of Deaths from COVID-19 and Seasonal Influenza in the USA. Lung. 2021;199:559&#x2013;561. doi: 10.1007/s00408-021-00468-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00468-0</ArticleId><ArticleId IdType="pmc">PMC8375609</ArticleId><ArticleId IdType="pubmed">34414503</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Yang C., Xu X.F., Xu W., Liu S. Structural and Functional Properties of SARS-CoV-2 Spike Protein: Potential Antivirus Drug Development for COVID-19. Acta Pharmacol. Sin. 2020;41:1141&#x2013;1149. doi: 10.1038/s41401-020-0485-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-020-0485-4</ArticleId><ArticleId IdType="pmc">PMC7396720</ArticleId><ArticleId IdType="pubmed">32747721</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou X., Chen K., Zou J., Han P., Hao J., Han Z. Single-Cell RNA-Seq Data Analysis on the Receptor ACE2 Expression Reveals the Potential Risk of Different Human Organs Vulnerable to 2019-NCoV Infection. Front. Med. 2020;14:185&#x2013;192. doi: 10.1007/s11684-020-0754-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-020-0754-0</ArticleId><ArticleId IdType="pmc">PMC7088738</ArticleId><ArticleId IdType="pubmed">32170560</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R., Wang K., Yu J., Howard D., French L., Chen Z., Wen C., Xu Z. The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains. Front. Neurol. 2021;11:1860. doi: 10.3389/fneur.2020.573095.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.573095</ArticleId><ArticleId IdType="pmc">PMC7855591</ArticleId><ArticleId IdType="pubmed">33551947</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenner A.L., Aogo R.A., Alfonso S., Crowe V., Deng X., Smith A.P., Morel P.A., Davis C.L., Smith A.M., Craig M. COVID-19 Virtual Patient Cohort Suggests Immune Mechanisms Driving Disease Outcomes. PLoS Pathog. 2021;17:e1009753. doi: 10.1371/journal.ppat.1009753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009753</ArticleId><ArticleId IdType="pmc">PMC8312984</ArticleId><ArticleId IdType="pubmed">34260666</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Soleimani J., Herasevich S., Pinevich Y., Pennington K.M., Dong Y., Pickering B.W., Barwise A.K. Clinical Characteristics, Treatment, and Outcomes of Critically Ill Patients with COVID-19: A Scoping Review. Mayo Clin. Proc. 2021;96:183&#x2013;202. doi: 10.1016/j.mayocp.2020.10.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.10.022</ArticleId><ArticleId IdType="pmc">PMC7586927</ArticleId><ArticleId IdType="pubmed">33413817</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T., Laenger F., Vanstapel A., Werlein C., Stark H., Tzankov A., et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N. Engl. J. Med. 2020;383:120&#x2013;128. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson R.W., Brown R.L., Benjamin L., Nortley R., Wiethoff S., Bharucha T., Jayaseelan D.L., Kumar G., Raftopoulos R.E., Zambreanu L., et al. The Emerging Spectrum of COVID-19 Neurology: Clinical, Radiological and Laboratory Findings. Brain. 2020;143:3104&#x2013;3120. doi: 10.1093/brain/awaa240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa240</ArticleId><ArticleId IdType="pmc">PMC7454352</ArticleId><ArticleId IdType="pubmed">32637987</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunutsor S.K., Laukkanen J.A. Renal Complications in COVID-19: A Systematic Review and Meta-Analysis. Ann. Med. 2020;52:345&#x2013;353. doi: 10.1080/07853890.2020.1790643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2020.1790643</ArticleId><ArticleId IdType="pmc">PMC7877945</ArticleId><ArticleId IdType="pubmed">32643418</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A., Gui J., Ahmad W., Haq I., Shahid M., Khan A.A., Shah A., Khan A., Ali L., Anwar Z., et al. The SARS-CoV-2 B.1.618 Variant Slightly Alters the Spike RBD-ACE2 Binding Affinity and Is an Antibody Escaping Variant: A Computational Structural Perspective. RSC Adv. 2021;11:30132&#x2013;30147. doi: 10.1039/D1RA04694B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D1RA04694B</ArticleId><ArticleId IdType="pmc">PMC9040812</ArticleId><ArticleId IdType="pubmed">35480256</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimeno-Almaz&#xe1;n A., Pallar&#xe9;s J.G., Buend&#xed;a-Romero &#xc1;., Mart&#xed;nez-Cava A., Franco-L&#xf3;pez F., S&#xe1;nchez-Alcaraz Mart&#xed;nez B.J., Bernal-Morel E., Courel-Ib&#xe1;&#xf1;ez J. Post-COVID-19 Syndrome and the Potential Benefits of Exercise. Int. J. Environ. Res. Public Health. 2021;18:5329. doi: 10.3390/ijerph18105329.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18105329</ArticleId><ArticleId IdType="pmc">PMC8156194</ArticleId><ArticleId IdType="pubmed">34067776</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis. 2022;1:jiac136. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Kohn L., Dauvrin M., Detollenaere J., Maertens de Noordhout C., Primus C., Cleemput I., Van der Heede K. Long COVID : Pathophysiology&#x2014;Epidemiology and Patient Needs. KCE Rep. 2021;1:1.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Naeije R., Caravita S. Phenotyping Long COVID. Eur. Respir. J. 2021;58:1. doi: 10.1183/13993003.01763-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01763-2021</ArticleId><ArticleId IdType="pmc">PMC8287735</ArticleId><ArticleId IdType="pubmed">34244323</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosato M., Carf&#xec; A., Martis I., Pais C., Ciciarello F., Rota E., Tritto M., Salerno A., Zazzara M.B., Martone A.M., et al. Prevalence and Predictors of Persistence of COVID-19 Symptoms in Older Adults: A Single-Center Study. J. Am. Med. Dir. Assoc. 2021;22:1840&#x2013;1844. doi: 10.1016/j.jamda.2021.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2021.07.003</ArticleId><ArticleId IdType="pmc">PMC8286874</ArticleId><ArticleId IdType="pubmed">34352201</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman E.L., Savelieff M.G., Hayek S.S., Pennathur S., Kretzler M., Pop-Busui R. Covid-19 and Diabetes: A Collision and Collusion of Two Diseases. Diabetes. 2020;69:2549&#x2013;2565. doi: 10.2337/dbi20-0032.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dbi20-0032</ArticleId><ArticleId IdType="pmc">PMC7679769</ArticleId><ArticleId IdType="pubmed">32938731</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C., Zurbuchen Y., Taeschler P., Ballouz T., Menges D., Hasler S., Adamo S., Raeber M.E., B&#xe4;chli E., Rudiger A., et al. Immunoglobulin Signature Predicts Risk of Post-Acute COVID-19 Syndrome. Nat. Commun. 2022;13:446. doi: 10.1038/s41467-021-27797-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27797-1</ArticleId><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J.W.Y., Su Q., Yeoh Y.K., Lui G.C.Y., Ng S.S.S., Zhang F., Li A.Y.L., Lu W., Hui D.S.C., et al. Gut Microbiota Dynamics in a Prospective Cohort of Patients with Post-Acute COVID-19 Syndrome. Gut. 2022;71:544&#x2013;552. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Lu S., Tang A.F., Durstenfeld M.S., Ho H.E., Goldberg S.A., Forman C.A., Munter S.E., Hoh R., Tai V., et al. Markers of Immune Activation and Inflammation in Individuals with Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J. Infect. Dis. 2021;224:1839&#x2013;1848. doi: 10.1093/infdis/jiab490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A., Khan T., Ali S., Aftab S., Wang Y., Qiankun W., Khan M., Suleman M., Ali S., Heng W., et al. SARS-CoV-2 New Variants: Characteristic Features and Impact on the Efficacy of Different Vaccines. Biomed. Pharmacother. 2021;143:112176. doi: 10.1016/j.biopha.2021.112176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.112176</ArticleId><ArticleId IdType="pmc">PMC8433040</ArticleId><ArticleId IdType="pubmed">34562770</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Chen D., Yuan D., Lausted C., Choi J., Dai C.L., Voillet V., Duvvuri V.R., Scherler K., Troisch P., et al. Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19. Cell. 2020;183:1479&#x2013;1495.e20. doi: 10.1016/j.cell.2020.10.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.037</ArticleId><ArticleId IdType="pmc">PMC7598382</ArticleId><ArticleId IdType="pubmed">33171100</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi R., Feng Z., Zhang X. Integrative Multi-Omics Landscape of Non-Structural Protein 3 of Severe Acute Respiratory Syndrome Coronaviruses. Genom. Proteom. Bioinform. 2021;19:707&#x2013;726. doi: 10.1016/j.gpb.2021.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gpb.2021.09.007</ArticleId><ArticleId IdType="pmc">PMC8578027</ArticleId><ArticleId IdType="pubmed">34774773</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Abdelrahman Z., Liu Q., Wang X., Chen Z. Comparisons of the Immunological Landscape of COVID-19 Patients Based on Sex and Disease Severity by Multi-Omics Analysis. Chem. Biol. Interact. 2022;352:109777. doi: 10.1016/j.cbi.2021.109777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2021.109777</ArticleId><ArticleId IdType="pmc">PMC8654707</ArticleId><ArticleId IdType="pubmed">34896122</ArticleId></ArticleIdList></Reference><Reference><Citation>Maras J.S., Sharma S., Bhat A., Rooge S., Aggrawal R., Gupta E., Sarin S.K. Multi-Omics Analysis of Respiratory Specimen Characterizes Baseline Molecular Determinants Associated with SARS-CoV-2 Outcome. iScience. 2021;24:102823. doi: 10.1016/j.isci.2021.102823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102823</ArticleId><ArticleId IdType="pmc">PMC8268673</ArticleId><ArticleId IdType="pubmed">34308298</ArticleId></ArticleIdList></Reference><Reference><Citation>Overmyer K.A., Shishkova E., Miller I.J., Balnis J., Bernstein M.N., Peters-Clarke T.M., Meyer J.G., Quan Q., Muehlbauer L.K., Trujillo E.A., et al. Large-Scale Multi-Omic Analysis of COVID-19 Severity. Cell Syst. 2021;12:23. doi: 10.1016/j.cels.2020.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2020.10.003</ArticleId><ArticleId IdType="pmc">PMC7543711</ArticleId><ArticleId IdType="pubmed">33096026</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardes J.P., Mishra N., Tran F., Bahmer T., Best L., Blase J.I., Bordoni D., Franzenburg J., Geisen U., Josephs-Spaulding J., et al. Longitudinal Multi-Omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19. Immunity. 2020;53:1296&#x2013;1314.e9. doi: 10.1016/j.immuni.2020.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.11.017</ArticleId><ArticleId IdType="pmc">PMC7689306</ArticleId><ArticleId IdType="pubmed">33296687</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano M., Ruggiero A., Squeglia F., Maga G., Berisio R. A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping. Cells. 2020;9:1267. doi: 10.3390/cells9051267.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9051267</ArticleId><ArticleId IdType="pmc">PMC7291026</ArticleId><ArticleId IdType="pubmed">32443810</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikh A., McMenamin J., Taylor B., Robertson C. SARS-CoV-2 Delta VOC in Scotland: Demographics, Risk of Hospital Admission, and Vaccine Effectiveness. Lancet. 2021;397:2461&#x2013;2462. doi: 10.1016/S0140-6736(21)01358-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01358-1</ArticleId><ArticleId IdType="pmc">PMC8201647</ArticleId><ArticleId IdType="pubmed">34139198</ArticleId></ArticleIdList></Reference><Reference><Citation>Faria N.R., Mellan T.A., Whittaker C., Claro I.M., Candido D.D.S., Mishra S., Crispim M.A.E., Sales F.C.S., Hawryluk I., McCrone J.T., et al. Genomics and Epidemiology of the P.1 SARS-CoV-2 Lineage in Manaus, Brazil. Science. 2021;372:815&#x2013;821. doi: 10.1126/science.abh2644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abh2644</ArticleId><ArticleId IdType="pmc">PMC8139423</ArticleId><ArticleId IdType="pubmed">33853970</ArticleId></ArticleIdList></Reference><Reference><Citation>Funk T., Pharris A., Spiteri G., Bundle N., Melidou A., Carr M., Gonzalez G., Garcia-Leon A., Crispie F., O&#x2019;Connor L., et al. Characteristics of SARS-CoV-2 Variants of Concern B.1.1.7, B.1.351 or P.1: Data from Seven EU/EEA Countries, Weeks 38/2020 to 10/2021. Eurosurveillance. 2021;26:2100348. doi: 10.2807/1560-7917.ES.2021.26.16.2100348.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.16.2100348</ArticleId><ArticleId IdType="pmc">PMC8063589</ArticleId><ArticleId IdType="pubmed">33890566</ArticleId></ArticleIdList></Reference><Reference><Citation>Tegally H., Wilkinson E., Giovanetti M., Iranzadeh A., Fonseca V., Giandhari J., Doolabh D., Pillay S., San E.J., Msomi N., et al. Detection of a SARS-CoV-2 Variant of Concern in South Africa. Nature. 2021;592:438&#x2013;443. doi: 10.1038/s41586-021-03402-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03402-9</ArticleId><ArticleId IdType="pubmed">33690265</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearson C.A. Estimates of Severity and Transmissibility of Novel South Africa SARS-CoV-2 Variant 501Y.V2.  [(accessed on 1 June 2022)].  Available online:  https://cmmid.github.io/topics/covid19/reports/sa-novel-variant/2021_01_11_Transmissibility_and_severity_of_501Y_V2_in_SA.pdf.</Citation></Reference><Reference><Citation>Wolter N., Jassat W., Walaza S., Welch R., Moultrie H., Groome M., Amoako D.G., Everatt J., Bhiman J.N., Scheepers C., et al. Early Assessment of the Clinical Severity of the SARS-CoV-2 Omicron Variant in South Africa. medRxiv. 2021 doi: 10.1101/2021.12.21.21268116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.12.21.21268116</ArticleId><ArticleId IdType="pmc">PMC8769664</ArticleId><ArticleId IdType="pubmed">35065011</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonager J., Bennedb&#xe6;k M., Bager P., Wohlfahrt J., Ellegaard K.M., Ingham A.C., Edslev S.M., Stegger M., Sieber R.N., Lassauniere R., et al. Molecular Epidemiology of the SARS-CoV-2 Variant Omicron BA.2 Sub-Lineage in Denmark, 29 November 2021 to 2 January 2022. Eurosurveillance. 2022;27:2200181. doi: 10.2807/1560-7917.ES.2022.27.10.2200181.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2022.27.10.2200181</ArticleId><ArticleId IdType="pmc">PMC8915403</ArticleId><ArticleId IdType="pubmed">35272746</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewnard J.A., Hong V.X., Patel M.M., Kahn R., Lipsitch M., Tartof S.Y. Clinical Outcomes among Patients Infected with Omicron (B.1.1.529) SARS-CoV-2 Variant in Southern California. medRxiv. 2022 doi: 10.1101/2022.01.11.22269045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.11.22269045</ArticleId><ArticleId IdType="pmc">PMC10208005</ArticleId><ArticleId IdType="pubmed">35675841</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen P.A., Olsen R.J., Long S.W., Snehal R., Davis J.J., Saavedra M.O., Reppond K., Shyer M.N., Cambric J., Gadd R., et al. Early Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with COVID-19 Caused by the Omicron Variant of SARS-CoV-2 in Houston, Texas. medRxiv. 2022 doi: 10.1101/2021.12.30.21268560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.12.30.21268560</ArticleId><ArticleId IdType="pmc">PMC8812084</ArticleId><ArticleId IdType="pubmed">35123975</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikh A., Kerr S., Woolhouse M., McMenamin J., Robertson C. Severity of Omicron Variant of Concern and Vaccine Effectiveness against Symptomatic Disease: National Cohort with Nested Test Negative Design Study in Scotland. Lancet Infect. Dis. 2021 doi: 10.1016/S1473-3099(22)00141-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00141-4</ArticleId><ArticleId IdType="pmc">PMC9033213</ArticleId><ArticleId IdType="pubmed">35468332</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyngse F.P., Mortensen L.H., Denwood M.J., Christiansen L.E., M&#xf8;ller C.H., Skov R.L., Spiess K., Fomsgaard A., Lassauni&#xe8;re M.M., Rasmussen M., et al. SARS-CoV-2 Omicron VOC Transmission in Danish Households. medRxiv. 2021 doi: 10.1101/2021.12.27.21268278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.12.27.21268278</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiological Update: SARS-CoV-2 Omicron Sub-Lineages BA.4 and BA.5.  [(accessed on 1 June 2022)].  Available online:  https://www.ecdc.europa.eu/en/news-events/epidemiological-update-sars-cov-2-omicron-sub-lineages-ba4-and-ba5.</Citation></Reference><Reference><Citation>Khan K., Karim F., Ganga Y., Bernstein M., Jule Z., Reedoy K., Cele S., Lustig G., Amoako D., Wolter N., et al. Omicron Sub-Lineages BA.4/BA.5 Escape BA.1 Infection Elicited Neutralizing Immunity. medRxiv. 2022 doi: 10.1101/2022.04.29.22274477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.04.29.22274477</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y., Yisimayi A., Jian F., Song W., Xiao T., Wang L., Du S., Wang J., Li Q., Chen X., et al. BA.2.12.1, BA.4 and BA.5 Escape Antibodies Elicited by Omicron Infection. bioRxiv. 2022 doi: 10.1038/s41586-022-04980-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04980-y</ArticleId><ArticleId IdType="pmc">PMC9385493</ArticleId><ArticleId IdType="pubmed">35714668</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell K.L., Pinski A.N., Clancy C.S., Gourdine T., Shifflett K., Fletcher P., Messaoudi I., Marzi A. Pathogenic and Transcriptomic Differences of Emerging SARS-CoV-2 Variants in the Syrian Golden Hamster Model. EBioMedicine. 2021;73:1. doi: 10.1016/j.ebiom.2021.103675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103675</ArticleId><ArticleId IdType="pmc">PMC8572342</ArticleId><ArticleId IdType="pubmed">34758415</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammad T., Choudhury A., Habib I., Asrani P., Mathur Y., Umair M., Anjum F., Shafie A., Yadav D.K., Hassan M.I. Genomic Variations in the Structural Proteins of SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative Genomics Approach. Front. Cell. Infect. Microbiol. 2021;11:951. doi: 10.3389/fcimb.2021.765039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.765039</ArticleId><ArticleId IdType="pmc">PMC8548870</ArticleId><ArticleId IdType="pubmed">34722346</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G., Hu C., Luo L., Fang F., Chen Y., Li J., Peng Z., Pan H. Clinical Features and Short-Term Outcomes of 221 Patients with COVID-19 in Wuhan, China. J. Clin. Virol. 2020;127:104364. doi: 10.1016/j.jcv.2020.104364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104364</ArticleId><ArticleId IdType="pmc">PMC7194884</ArticleId><ArticleId IdType="pubmed">32311650</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassetti M., Kollef M.H., Timsit J.F. Bacterial and Fungal Superinfections in Critically Ill Patients with COVID-19. Intensive Care Med. 2020;46:2071&#x2013;2074. doi: 10.1007/s00134-020-06219-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06219-8</ArticleId><ArticleId IdType="pmc">PMC7479998</ArticleId><ArticleId IdType="pubmed">32902729</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann C.J., Pho M.T., Pitrak D., Ridgway J.P., Pettit N.N. Community-Acquired Coinfection in Coronavirus Disease 2019: A Retrospective Observational Experience. Clin. Infect. Dis. 2021;72:1450&#x2013;1452. doi: 10.1093/cid/ciaa902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa902</ArticleId><ArticleId IdType="pmc">PMC7337635</ArticleId><ArticleId IdType="pubmed">32604413</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y., Yang Q., Xu M., Kong H., Chen H., Fu Y., Yao Y., Zhou H., Zhou J. Secondary Bacterial Infections in Critical Ill Patients with Coronavirus Disease 2019. Open Forum Infect. Dis. 2020;7:ofaa220. doi: 10.1093/ofid/ofaa220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa220</ArticleId><ArticleId IdType="pmc">PMC7313762</ArticleId><ArticleId IdType="pubmed">32613024</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoque M.N., Rahman M.S., Ahmed R., Hossain M.S., Islam M.S., Islam T., Hossain M.A., Siddiki A.Z. Diversity and Genomic Determinants of the Microbiomes Associated with COVID-19 and Non-COVID Respiratory Diseases. Gene Rep. 2021;23:101200. doi: 10.1016/j.genrep.2021.101200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genrep.2021.101200</ArticleId><ArticleId IdType="pmc">PMC8102076</ArticleId><ArticleId IdType="pubmed">33977168</ArticleId></ArticleIdList></Reference><Reference><Citation>Sencio V., Machado M.G., Trottein F. The Lung&#x2013;Gut Axis during Viral Respiratory Infections: The Impact of Gut Dysbiosis on Secondary Disease Outcomes. Mucosal Immunol. 2021;14:296. doi: 10.1038/s41385-020-00361-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-020-00361-8</ArticleId><ArticleId IdType="pmc">PMC7835650</ArticleId><ArticleId IdType="pubmed">33500564</ArticleId></ArticleIdList></Reference><Reference><Citation>Rekdal V.M., Bess E.N., Bisanz J.E., Turnbaugh P.J., Balskus E.P. Discovery and Inhibition of an Interspecies Gut Bacterial Pathway for Levodopa Metabolism. Science. 2019;364:1. doi: 10.1126/SCIENCE.AAU6323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCIENCE.AAU6323</ArticleId><ArticleId IdType="pmc">PMC7745125</ArticleId><ArticleId IdType="pubmed">31196984</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee-Sarwar K.A., Lasky-Su J., Kelly R.S., Litonjua A.A., Weiss S.T. Gut Microbial-Derived Metabolomics of Asthma. Metabolites. 2020;10:97. doi: 10.3390/metabo10030097.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo10030097</ArticleId><ArticleId IdType="pmc">PMC7142494</ArticleId><ArticleId IdType="pubmed">32155960</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang W.H.W., Wang Z., Levison B.S., Koeth R.A., Britt E.B., Fu X., Wu Y., Hazen S.L. Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk. N. Engl. J. Med. 2013;368:1575. doi: 10.1056/NEJMoa1109400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1109400</ArticleId><ArticleId IdType="pmc">PMC3701945</ArticleId><ArticleId IdType="pubmed">23614584</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoque M.N., Sarkar M.H., Rahman M.S., Akter S., Banu T.A., Goswami B., Jahan I., Hossain M.S., Shamsuzzaman A.K.M., Nafisa T., et al. SARS-CoV-2 Infection Reduces Human Nasopharyngeal Commensal Microbiome with Inclusion of Pathobionts. Sci. Rep. 2021;11:24042. doi: 10.1038/s41598-021-03245-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-03245-4</ArticleId><ArticleId IdType="pmc">PMC8674272</ArticleId><ArticleId IdType="pubmed">34911967</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J., Yatim N., Barnabei L., Corneau A., Boussier J., Smith N., P&#xe9;r&#xe9; H., Charbit B., Bondet V., Chenevier-Gobeaux C., et al. Impaired Type I Interferon Activity and Inflammatory Responses in Severe COVID-19 Patients. Science. 2020;369:718&#x2013;724. doi: 10.1126/science.abc6027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6027</ArticleId><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Tan Y., Ling Y., Lu G., Liu F., Yi Z., Jia X., Wu M., Shi B., Xu S., et al. Viral and Host Factors Related to the Clinical Outcome of COVID-19. Nature. 2020;583:437&#x2013;440. doi: 10.1038/s41586-020-2355-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2355-0</ArticleId><ArticleId IdType="pubmed">32434211</ArticleId></ArticleIdList></Reference><Reference><Citation>Lokugamage K.G., Hage A., de Vries M., Valero-Jimenez A.M., Schindewolf C., Dittmann M., Rajsbaum R., Menachery V.D. Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV. J. Virol. 2020;94:1. doi: 10.1128/JVI.01410-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01410-20</ArticleId><ArticleId IdType="pmc">PMC7654262</ArticleId><ArticleId IdType="pubmed">32938761</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee A.K., Blanco M.R., Bruce E.A., Honson D.D., Chen L.M., Chow A., Bhat P., Ollikainen N., Quinodoz S.A., Loney C., et al. SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses. Cell. 2020;183:1325&#x2013;1339.e21. doi: 10.1016/j.cell.2020.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.004</ArticleId><ArticleId IdType="pmc">PMC7543886</ArticleId><ArticleId IdType="pubmed">33080218</ArticleId></ArticleIdList></Reference><Reference><Citation>Obitsu S., Ahmed N., Nishitsuji H., Hasegawa A., Nakahama K., Morita I., Nishigaki K., Hayashi T., Masuda T., Kannagi M. Potential Enhancement of Osteoclastogenesis by Severe Acute Respiratory Syndrome Coronavirus 3a/X1 Protein. Arch. Virol. 2009;154:1457&#x2013;1464. doi: 10.1007/s00705-009-0472-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-009-0472-z</ArticleId><ArticleId IdType="pmc">PMC7086770</ArticleId><ArticleId IdType="pubmed">19685004</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnamoorthy P., Raj A.S., Roy S., Kumar N.S., Kumar H. Comparative Transcriptome Analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to Identify Potential Pathways for Drug Repurposing. Comput. Biol. Med. 2021;128:104123. doi: 10.1016/j.compbiomed.2020.104123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2020.104123</ArticleId><ArticleId IdType="pmc">PMC7683955</ArticleId><ArticleId IdType="pubmed">33260034</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul S., Bravo V&#xe1;zquez L.A., Reyes-P&#xe9;rez P.R., Estrada-Meza C., Aponte Alburquerque R.A., Pathak S., Banerjee A., Bandyopadhyay A., Chakraborty S., Srivastava A. The Role of MicroRNAs in Solving COVID-19 Puzzle from Infection to Therapeutics: A Mini-Review. Virus Res. 2022;308:198631. doi: 10.1016/j.virusres.2021.198631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2021.198631</ArticleId><ArticleId IdType="pmc">PMC8590742</ArticleId><ArticleId IdType="pubmed">34788642</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynaert N.L., Gopal P., Rutten E.P.A., Wouters E.F.M., Schalkwijk C.G. Advanced Glycation End Products and Their Receptor in Age-Related, Non-Communicable Chronic Inflammatory Diseases; Overview of Clinical Evidence and Potential Contributions to Disease. Int. J. Biochem. Cell Biol. 2016;81:403&#x2013;418. doi: 10.1016/j.biocel.2016.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2016.06.016</ArticleId><ArticleId IdType="pubmed">27373680</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad K. AGE-RAGE Stress in the Pathophysiology of Pulmonary Hypertension and Its Treatment. Int. J. Angiol. 2019;28:71&#x2013;79. doi: 10.1055/s-0039-1687818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-1687818</ArticleId><ArticleId IdType="pmc">PMC6679961</ArticleId><ArticleId IdType="pubmed">31384104</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosmopoulos M., Drekolias D., Zavras P.D., Piperi C., Papavassiliou A.G. Impact of Advanced Glycation End Products (AGEs) Signaling in Coronary Artery Disease. Biochim. Et Biophys. Acta Mol. Basis Dis. 2019;1865:611&#x2013;619. doi: 10.1016/j.bbadis.2019.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2019.01.006</ArticleId><ArticleId IdType="pubmed">30611860</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepahi A., Kraus A., Casadei E., Johnston C.A., Galindo-Villegas J., Kelly C., Garc&#xed;a-Moreno D., Mu&#xf1;oz P., Mulero V., Huertas M., et al. Olfactory Sensory Neurons Mediate Ultrarapid Antiviral Immune Responses in a TrkA-Dependent Manner. Proc. Natl. Acad. Sci. USA. 2019;116:12428&#x2013;12436. doi: 10.1073/pnas.1900083116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1900083116</ArticleId><ArticleId IdType="pmc">PMC6589677</ArticleId><ArticleId IdType="pubmed">31160464</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Chiesa-Estomba C.M., de Siati D.R., Horoi M., le Bon S.D., Rodriguez A., Dequanter D., Blecic S., el Afia F., Distinguin L., et al. Olfactory and Gustatory Dysfunctions as a Clinical Presentation of Mild-to-Moderate Forms of the Coronavirus Disease (COVID-19): A Multicenter European Study. Eur. Arch. Oto Rhino Laryngol. 2020;277:2251&#x2013;2261. doi: 10.1007/s00405-020-05965-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-05965-1</ArticleId><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan C.H., Faraji F., Prajapati D.P., Ostrander B.T., DeConde A.S. Self-Reported Olfactory Loss Associates with Outpatient Clinical Course in COVID-19. Int. Forum Allergy Rhinol. 2020;10:821&#x2013;831. doi: 10.1002/alr.22592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22592</ArticleId><ArticleId IdType="pmc">PMC7264572</ArticleId><ArticleId IdType="pubmed">32329222</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilinska K., Jakubowska P., von Bartheld C.S., Butowt R. Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age. ACS Chem. Neurosci. 2020;11:1555&#x2013;1562. doi: 10.1021/acschemneuro.0c00210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00210</ArticleId><ArticleId IdType="pmc">PMC7241737</ArticleId><ArticleId IdType="pubmed">32379417</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercatelli D., Pedace E., Veltri P., Giorgi F.M., Guzzi P.H. Exploiting the Molecular Basis of Age and Gender Differences in Outcomes of SARS-CoV-2 Infections. Comput. Struct. Biotechnol. J. 2021;19:4092&#x2013;4100. doi: 10.1016/j.csbj.2021.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2021.07.002</ArticleId><ArticleId IdType="pmc">PMC8271029</ArticleId><ArticleId IdType="pubmed">34306570</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell L.C.K., Meydan C., Kim J., Foox J., Butler D., Mason C.E., Shapira S.D., Noursadeghi M., Pollara G. Transcriptional Response Modules Characterize IL-1&#x3b2; and IL-6 Activity in COVID-19. iScience. 2021;24:101896. doi: 10.1016/j.isci.2020.101896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101896</ArticleId><ArticleId IdType="pmc">PMC7721347</ArticleId><ArticleId IdType="pubmed">33319166</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvin A., Chapuis N., Dunsmore G., Goubet A.G., Dubuisson A., Derosa L., Almire C., H&#xe9;non C., Kosmider O., Droin N., et al. Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19. Cell. 2020;182:1401&#x2013;1418.e18. doi: 10.1016/j.cell.2020.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.002</ArticleId><ArticleId IdType="pmc">PMC7405878</ArticleId><ArticleId IdType="pubmed">32810439</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasparello J., Finotti A., Gambari R. Tackling the COVID-19 &#x201c;Cytokine Storm&#x201d; with MicroRNA Mimics Directly Targeting the 3&#x2019;UTR of pro-Inflammatory MRNAs. Med. Hypotheses. 2021;146:110415. doi: 10.1016/j.mehy.2020.110415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110415</ArticleId><ArticleId IdType="pmc">PMC7685948</ArticleId><ArticleId IdType="pubmed">33422363</ArticleId></ArticleIdList></Reference><Reference><Citation>Thair S.A., He Y.D., Hasin-Brumshtein Y., Sakaram S., Pandya R., Toh J., Rawling D., Remmel M., Coyle S., Dalekos G.N., et al. Transcriptomic Similarities and Differences in Host Response between SARS-CoV-2 and Other Viral Infections. iScience. 2021;24:101947. doi: 10.1016/j.isci.2020.101947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101947</ArticleId><ArticleId IdType="pmc">PMC7786129</ArticleId><ArticleId IdType="pubmed">33437935</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyler E., M&#xf6;sbauer K., Franke V., Diag A., Gottula L.T., Arsi&#xe8; R., Klironomos F., Koppstein D., H&#xf6;nzke K., Ayoub S., et al. Transcriptomic Profiling of SARS-CoV-2 Infected Human Cell Lines Identifies HSP90 as Target for COVID-19 Therapy. iScience. 2021;24:102151. doi: 10.1016/j.isci.2021.102151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102151</ArticleId><ArticleId IdType="pmc">PMC7866843</ArticleId><ArticleId IdType="pubmed">33585804</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler C.G.K., Miao V.N., Owings A.H., Navia A.W., Tang Y., Bromley J.D., Lotfy P., Sloan M., Laird H., Williams H.B., et al. Impaired Local Intrinsic Immunity to SARS-CoV-2 Infection in Severe COVID-19. Cell. 2021;184:4713&#x2013;4733.e22. doi: 10.1016/j.cell.2021.07.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.07.023</ArticleId><ArticleId IdType="pmc">PMC8299217</ArticleId><ArticleId IdType="pubmed">34352228</ArticleId></ArticleIdList></Reference><Reference><Citation>Vishnubalaji R., Shaath H., Alajez N.M. Protein Coding and Long Noncoding RNA (LncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response. Genes. 2020;11:760. doi: 10.3390/genes11070760.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes11070760</ArticleId><ArticleId IdType="pmc">PMC7397219</ArticleId><ArticleId IdType="pubmed">32646047</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng J., Zhou X., Feng W., Jia M., Zhang X., An T., Luan M., Pan Y., Zhang S., Zhou Z., et al. Risk Stratification by Long Non-Coding RNAs Profiling in COVID-19 Patients. J. Cell. Mol. Med. 2021;25:4753&#x2013;4764. doi: 10.1111/jcmm.16444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.16444</ArticleId><ArticleId IdType="pmc">PMC8107096</ArticleId><ArticleId IdType="pubmed">33759345</ArticleId></ArticleIdList></Reference><Reference><Citation>Turjya R.R., Khan M.A.A.K., Mir Md Khademul Islam A.B. Perversely Expressed Long Noncoding RNAs Can Alter Host Response and Viral Proliferation in SARS-CoV-2 Infection. Future Virol. 2020;15:577&#x2013;593. doi: 10.2217/fvl-2020-0188.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fvl-2020-0188</ArticleId><ArticleId IdType="pmc">PMC7664154</ArticleId><ArticleId IdType="pubmed">33224264</ArticleId></ArticleIdList></Reference><Reference><Citation>Damas N.D., Fossat N., Scheel T.K.H. Non-Coding RNA Review Functional Interplay between RNA Viruses and Non-Coding RNA in Mammals. Noncoding RNA. 2019;5:7. doi: 10.3390/ncrna5010007.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ncrna5010007</ArticleId><ArticleId IdType="pmc">PMC6468702</ArticleId><ArticleId IdType="pubmed">30646609</ArticleId></ArticleIdList></Reference><Reference><Citation>Henao-Mejia J., He X., Wang P. The Opening of Pandora&#x2019;s Box: An Emerging Role of Long Noncoding RNA in Viral Infections. Front. Immunol. 2019;1:3138. doi: 10.3389/fimmu.2018.03138.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.03138</ArticleId><ArticleId IdType="pmc">PMC6355698</ArticleId><ArticleId IdType="pubmed">30740112</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta R., Leimanis M.L., Adams M., Bachmann A.S., Uhl K.L., Bupp C.P., Hartog N.L., Kort E.J., Olivero R., Comstock S.S., et al. Balancing Precision versus Cohort Transcriptomic Analysis of Acute and Recovery Phase of Viral Bronchiolitis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2021;320:L1147&#x2013;L1157. doi: 10.1152/ajplung.00440.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00440.2020</ArticleId><ArticleId IdType="pmc">PMC8285625</ArticleId><ArticleId IdType="pubmed">33851876</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhead B., Brorson I.S., Berge T., Adams C., Quach H., Moen S.M., Berg-Hansen P., Celius E.G., Sangurdekar D.P., Bronson P.G., et al. Increased DNA Methylation of SLFN12 in CD4 + and CD8 + T Cells from Multiple Sclerosis Patients. PLoS ONE. 2018;13:e0206511. doi: 10.1371/journal.pone.0206511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0206511</ArticleId><ArticleId IdType="pmc">PMC6209300</ArticleId><ArticleId IdType="pubmed">30379917</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Sun H., Hu Z., Mei P., Wu Y., Zhu M. NUTM2A-AS1 Silencing Alleviates LPS-Induced Apoptosis and Inflammation in Dental Pulp Cells through Targeting Let-7c-5p/HMGB1 Axis. Int. Immunopharmacol. 2021;96:107497. doi: 10.1016/j.intimp.2021.107497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107497</ArticleId><ArticleId IdType="pubmed">33831808</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lima D.S., Cardozo L.E., Maracaja-Coutinho V., Suhrbier A., Mane K., Jeffries D., Silveira E.L.V., Amaral P.P., Rappuoli R., de Silva T.I., et al. Long Noncoding RNAs Are Involved in Multiple Immunological Pathways in Response to Vaccination. Proc. Natl. Acad. Sci. USA. 2019;116:17121&#x2013;17126. doi: 10.1073/pnas.1822046116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1822046116</ArticleId><ArticleId IdType="pmc">PMC6708379</ArticleId><ArticleId IdType="pubmed">31399544</ArticleId></ArticleIdList></Reference><Reference><Citation>Talotta R., Bahrami S., Laska M.J. Sequence Complementarity between Human Noncoding RNAs and SARS-CoV-2 Genes: What Are the Implications for Human Health? Biochim. Et Biophys. Acta Mol. Basis Dis. 2022;1868:166291. doi: 10.1016/j.bbadis.2021.166291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2021.166291</ArticleId><ArticleId IdType="pmc">PMC8518135</ArticleId><ArticleId IdType="pubmed">34662705</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang C., Cheng S., Zhang Y., Sun Y., Fernie A.R., Kang K., Panagiotou G., Lo C., Lim B.L. Transcriptomic, Proteomic and Metabolic Changes in Arabidopsis Thaliana Leaves after the Onset of Illumination. BMC Plant Biol. 2016;16:43. doi: 10.1186/s12870-016-0726-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12870-016-0726-3</ArticleId><ArticleId IdType="pmc">PMC4750186</ArticleId><ArticleId IdType="pubmed">26865323</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y., Deng M., Zhao Z., Fan G. Quantitative Proteomic and Transcriptomic Study on Autotetraploid Paulownia and Its Diploid Parent Reveal Key Metabolic Processes Associated with Paulownia Autotetraploidization. Front. Plant Sci. 2016;7:892. doi: 10.3389/fpls.2016.00892.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpls.2016.00892</ArticleId><ArticleId IdType="pmc">PMC4919355</ArticleId><ArticleId IdType="pubmed">27446122</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzoni C., Kia D.A., Vandrovcova J., Hardy J., Wood N.W., Lewis P.A., Ferrari R. Genome, Transcriptome and Proteome: The Rise of Omics Data and Their Integration in Biomedical Sciences. Brief. Bioinform. 2018;19:286&#x2013;302. doi: 10.1093/bib/bbw114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbw114</ArticleId><ArticleId IdType="pmc">PMC6018996</ArticleId><ArticleId IdType="pubmed">27881428</ArticleId></ArticleIdList></Reference><Reference><Citation>Bathke J., Konzer A., Remes B., McIntosh M., Klug G. Comparative Analyses of the Variation of the Transcriptome and Proteome of Rhodobacter Sphaeroides throughout Growth. BMC Genom. 2019;20:358. doi: 10.1186/s12864-019-5749-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12864-019-5749-3</ArticleId><ArticleId IdType="pmc">PMC6509803</ArticleId><ArticleId IdType="pubmed">31072330</ArticleId></ArticleIdList></Reference><Reference><Citation>Lem&#xe9;e J.M., Clavreul A., Aubry M., Com E., de Tayrac M., Mosser J., Menei P. Integration of Transcriptome and Proteome Profiles in Glioblastoma: Looking for the Missing Link. BMC Mol. Biol. 2018;19:13. doi: 10.1186/s12867-018-0115-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12867-018-0115-6</ArticleId><ArticleId IdType="pmc">PMC6249855</ArticleId><ArticleId IdType="pubmed">30463513</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y., Wang S., Zhong H., Yang Q., Zhang F., Zhuang Z., Yuan J., Nie X., Wang S. Integrative Analyses Reveal Transcriptome-Proteome Correlation in Biological Pathways and Secondary Metabolism Clusters in A. Flavus in Response to Temperature. Sci. Rep. 2015;5:14582. doi: 10.1038/srep14582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep14582</ArticleId><ArticleId IdType="pmc">PMC4586720</ArticleId><ArticleId IdType="pubmed">26416011</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunawardana Y., Niranjan M. Bridging the Gap between Transcriptome and Proteome Measurements Identifies Post-Translationally Regulated Genes. Bioinformatics. 2013;29:3060&#x2013;3066. doi: 10.1093/bioinformatics/btt537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt537</ArticleId><ArticleId IdType="pubmed">24045772</ArticleId></ArticleIdList></Reference><Reference><Citation>Mcardle A., Washington K.E., Orgel C., Binek A., Manalo D.-M., Rivas A., Ayres M., Pandey R., Phebus C., Raedschelders K., et al. Discovery Proteomics for COVID-19: Where We Are Now. J. Proteome Res. 2021;20:4627&#x2013;4639. doi: 10.1021/acs.jproteome.1c00475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00475</ArticleId><ArticleId IdType="pmc">PMC8482317</ArticleId><ArticleId IdType="pubmed">34550702</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J., Kim H., Kim S.Y., Kim Y., Lee J.S., Dan K., Seong M.W., Han D. In-Depth Blood Proteome Profiling Analysis Revealed Distinct Functional Characteristics of Plasma Proteins between Severe and Non-Severe COVID-19 Patients. Sci. Rep. 2020;10:1&#x2013;10. doi: 10.1038/s41598-020-80120-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-80120-8</ArticleId><ArticleId IdType="pmc">PMC7772338</ArticleId><ArticleId IdType="pubmed">33376242</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong W., Altay O., Arif M., Edfors F., Doganay L., Mardinoglu A., Uhlen M., Fagerberg L. Next Generation Plasma Proteome Profiling of COVID-19 Patients with Mild to Moderate Symptoms. eBioMedicine. 2021;74:103723. doi: 10.1016/j.ebiom.2021.103723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103723</ArticleId><ArticleId IdType="pmc">PMC8626206</ArticleId><ArticleId IdType="pubmed">34844191</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Alessandro A., Thomas T., Dzieciatkowska M., Hill R.C., Francis R.O., Hudson K.E., Zimring J.C., Hod E.A., Spitalnik S.L., Hansen K.C. Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL-6 Level. J. Proteome Res. 2020;19:4417&#x2013;4427. doi: 10.1021/acs.jproteome.0c00365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.0c00365</ArticleId><ArticleId IdType="pmc">PMC7640953</ArticleId><ArticleId IdType="pubmed">32786691</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Zhang J., Yang Y., Ma H., Li Z., Zhang J., Cheng J., Zhang X., Zhao Y., Xia Z., et al. The Role of Interleukin-6 in Monitoring Severe Case of Coronavirus Disease 2019. EMBO Mol. Med. 2020;12:e12421. doi: 10.15252/emmm.202012421.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202012421</ArticleId><ArticleId IdType="pmc">PMC7280589</ArticleId><ArticleId IdType="pubmed">32428990</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendt R., Kalbitz S., L&#xfc;bbert C., Kellner N., Macholz M., Schroth S., Ermisch J., Latosisnka A., Arnold B., Mischak H., et al. Urinary Peptides Significantly Associate with COVID-19 Severity: Pilot Proof-of-Principle Data and Design of a Multicentric Diagnostic Study. Proteomics. 2020;20:2000202. doi: 10.1002/pmic.202000202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.202000202</ArticleId><ArticleId IdType="pubmed">32960510</ArticleId></ArticleIdList></Reference><Reference><Citation>Haljasm&#xe4;gi L., Salumets A., Rumm A.P., J&#xfc;rgenson M., Krassohhina E., Remm A., Sein H., Kareinen L., Vapalahti O., Sironen T., et al. Longitudinal Proteomic Profiling Reveals Increased Early Inflammation and Sustained Apoptosis Proteins in Severe COVID-19. Sci. Rep. 2020;10:20533. doi: 10.1038/s41598-020-77525-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-77525-w</ArticleId><ArticleId IdType="pmc">PMC7689507</ArticleId><ArticleId IdType="pubmed">33239683</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser D.D., Cepinskas G., Patterson E.K., Slessarev M., Martin C., Daley M., Patel M.A., Miller M.R., O&#x2019;Gorman D.B., Gill S.E., et al. Novel Outcome Biomarkers Identified with Targeted Proteomic Analyses of Plasma From Critically Ill Coronavirus Disease 2019 Patients. Crit. Care Explor. 2020;2:e0189. doi: 10.1097/CCE.0000000000000189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000189</ArticleId><ArticleId IdType="pmc">PMC7449255</ArticleId><ArticleId IdType="pubmed">32904064</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen B., Yi X., Sun Y., Bi X., Du J., Zhang C., Quan S., Zhang F., Sun R., Qian L., et al. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. Cell. 2020;182:59&#x2013;72.e15. doi: 10.1016/j.cell.2020.05.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.032</ArticleId><ArticleId IdType="pmc">PMC7254001</ArticleId><ArticleId IdType="pubmed">32492406</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu T., Ning W., Wu D., Xu J., Han Q., Huang M., Zou X., Yang Q., Yuan Y., Bie Y., et al. Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19. Immunity. 2020;53:1108&#x2013;1122.e5. doi: 10.1016/j.immuni.2020.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.10.008</ArticleId><ArticleId IdType="pmc">PMC7574896</ArticleId><ArticleId IdType="pubmed">33128875</ArticleId></ArticleIdList></Reference><Reference><Citation>The Severe Covid-19 GWAS Group Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N. Engl. J. Med. 2020;383:1522&#x2013;1534. doi: 10.1056/NEJMoa2020283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2020283</ArticleId><ArticleId IdType="pmc">PMC7315890</ArticleId><ArticleId IdType="pubmed">32558485</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeberg H., P&#xe4;&#xe4;bo S. A Genomic Region Associated with Protection against Severe COVID-19 Is Inherited from Neandertals. Proc. Natl. Acad. Sci. USA. 2021;118:e2026309118. doi: 10.1073/pnas.2026309118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2026309118</ArticleId><ArticleId IdType="pmc">PMC7936282</ArticleId><ArticleId IdType="pubmed">33593941</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeberg H., P&#xe4;&#xe4;bo S. The Major Genetic Risk Factor for Severe COVID-19 Is Inherited from Neanderthals. Nature. 2020;587:610&#x2013;612. doi: 10.1038/s41586-020-2818-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2818-3</ArticleId><ArticleId IdType="pubmed">32998156</ArticleId></ArticleIdList></Reference><Reference><Citation>Huffman J.E., Butler-Laporte G., Khan A., Pairo-Castineira E., Drivas T.G., Peloso G.M., Nakanishi T., Ganna A., Verma A., Baillie J.K., et al. Multi-Ancestry Fine Mapping Implicates OAS1 Splicing in Risk of Severe COVID-19. Nat. Genet. 2022;54:125&#x2013;127. doi: 10.1038/s41588-021-00996-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00996-8</ArticleId><ArticleId IdType="pmc">PMC8837537</ArticleId><ArticleId IdType="pubmed">35027740</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi U.Y., Kang J.S., Hwang Y.S., Kim Y.J. Oligoadenylate Synthase-like (OASL) Proteins: Dual Functions and Associations with Diseases. Exp. Mol. Med. 2015;47:e144. doi: 10.1038/emm.2014.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2014.110</ArticleId><ArticleId IdType="pmc">PMC4351405</ArticleId><ArticleId IdType="pubmed">25744296</ArticleId></ArticleIdList></Reference><Reference><Citation>Pairo-Castineira E., Clohisey S., Klaric L., Bretherick A.D., Rawlik K., Pasko D., Walker S., Parkinson N., Fourman M.H., Russell C.D., et al. Genetic Mechanisms of Critical Illness in COVID-19. Nature. 2021;591:92&#x2013;98. doi: 10.1038/s41586-020-03065-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-03065-y</ArticleId><ArticleId IdType="pubmed">33307546</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S., Butler-Laporte G., Nakanishi T., Morrison D.R., Afilalo J., Afilalo M., Laurent L., Pietzner M., Kerrison N., Zhao K., et al. A Neanderthal OAS1 Isoform Protects Individuals of European Ancestry against COVID-19 Susceptibility and Severity. Nat. Med. 2021;27:659&#x2013;667. doi: 10.1038/s41591-021-01281-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01281-1</ArticleId><ArticleId IdType="pubmed">33633408</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakanishi T., Pigazzini S., Degenhardt F., Cordioli M., Butler-Laporte G., Maya-Miles D., Bujanda L., Bouysran Y., Niemi M.E.K., Palom A., et al. Age-Dependent Impact of the Major Common Genetic Risk Factor for COVID-19 on Severity and Mortality. J. Clin. Investig. 2021;131 doi: 10.1172/JCI152386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI152386</ArticleId><ArticleId IdType="pmc">PMC8631592</ArticleId><ArticleId IdType="pubmed">34597274</ArticleId></ArticleIdList></Reference><Reference><Citation>Vuille-Dit-Bille R.N., Camargo S.M., Emmenegger L., Sasse T., Kummer E., Jando J., Hamie Q.M., Meier C.F., Hunziker S., Forras-Kaufmann Z., et al. Human Intestine Luminal ACE2 and Amino Acid Transporter Expression Increased by ACE-Inhibitors. Amino Acids. 2015;47:693&#x2013;705. doi: 10.1007/s00726-014-1889-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-014-1889-6</ArticleId><ArticleId IdType="pubmed">25534429</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Host Genetics Initiative Mapping the Human Genetic Architecture of COVID-19. Nature. 2021;600:472&#x2013;477. doi: 10.1038/s41586-021-03767-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03767-x</ArticleId><ArticleId IdType="pmc">PMC8674144</ArticleId><ArticleId IdType="pubmed">34237774</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe9;rard C., Maggipinto G., Minon J.M. COVID-19 and ABO Blood Group: Another Viewpoint. Br. J. Haematol. 2020;190:e93&#x2013;e94. doi: 10.1111/bjh.16884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16884</ArticleId><ArticleId IdType="pmc">PMC7283642</ArticleId><ArticleId IdType="pubmed">32453863</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Balmat T.J., Antonia A.L., Constantine F.J., Henao R., Burke T.W., Ingham A., McClain M.T., Tsalik E.L., Ko E.R., et al. An Atlas Connecting Shared Genetic Architecture of Human Diseases and Molecular Phenotypes Provides Insight into COVID-19 Susceptibility. Genome Med. 2021;13:1&#x2013;19. doi: 10.1186/s13073-021-00904-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-021-00904-z</ArticleId><ArticleId IdType="pmc">PMC8127495</ArticleId><ArticleId IdType="pubmed">34001247</ArticleId></ArticleIdList></Reference><Reference><Citation>Horowitz J.E., Kosmicki J.A., Damask A., Sharma D., Roberts G.H.L., Justice A.E., Banerjee N., Coignet M.V., Yadav A., Leader J.B., et al. Genome-Wide Analysis in 756,646 Individuals Provides First Genetic Evidence That ACE2 Expression Influences COVID-19 Risk and Yields Genetic Risk Scores Predictive of Severe Disease. medRxiv. 2021 doi: 10.1101/2020.12.14.20248176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.14.20248176</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Geiss-Friedlander R., Parmentier N., M&#xf6;ller U., Urlaub H., van den Eynde B.J., Melchoir F. The Cytoplasmic Peptidase DPP9 Is Rate-Limiting for Degradation of Proline-Containing Peptides. J. Biol. Chem. 2009;284:27211&#x2013;27219. doi: 10.1074/jbc.M109.041871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.041871</ArticleId><ArticleId IdType="pmc">PMC2785648</ArticleId><ArticleId IdType="pubmed">19667070</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen A., David J.K., Maden S.K., Wood M.A., Weeder B.R., Nellore A., Thompson R.F. Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2. J. Virol. 2020;94:e00510&#x2013;e00520. doi: 10.1128/JVI.00510-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00510-20</ArticleId><ArticleId IdType="pmc">PMC7307149</ArticleId><ArticleId IdType="pubmed">32303592</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J., Wan Y., Luo C., Ye G., Geng Q., Auerbach A., Li F. Cell Entry Mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. USA. 2020;117:11727&#x2013;11734. doi: 10.1073/pnas.2003138117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2003138117</ArticleId><ArticleId IdType="pmc">PMC7260975</ArticleId><ArticleId IdType="pubmed">32376634</ArticleId></ArticleIdList></Reference><Reference><Citation>Kousathanas A., Pairo-Castineira E., Rawlik K., Stuckey A., Odhams C.A., Walker S., Russell C.D., Malinauskas T., Wu Y., Millar J., et al. Whole Genome Sequencing Reveals Host Factors Underlying Critical COVID-19. Nature. 2022;1:1&#x2013;10. doi: 10.1038/s41586-022-04576-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04576-6</ArticleId><ArticleId IdType="pmc">PMC9259496</ArticleId><ArticleId IdType="pubmed">35255492</ArticleId></ArticleIdList></Reference><Reference><Citation>Murodzhon A., Alberto A., Montemanni R., Francesco B., Ivo K. OmicsNet: Integration of Multi-Omics Data Using Path Analysis in Multilayer Networks. bioRxiv. 2020 doi: 10.1101/238766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/238766</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharifi-Noghabi H., Zolotareva O., Collins C.C., Ester M. MOLI: Multi-Omics Late Integration with Deep Neural Networks for Drug Response Prediction. Bioinformatics. 2019;35:i501&#x2013;i509. doi: 10.1093/bioinformatics/btz318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btz318</ArticleId><ArticleId IdType="pmc">PMC6612815</ArticleId><ArticleId IdType="pubmed">31510700</ArticleId></ArticleIdList></Reference><Reference><Citation>Rappoport N., Safra R., Shamir R. MONET: Multi-Omic Module Discovery by Omic Selection. PLOS Comput. Biol. 2020;16:e1008182. doi: 10.1371/journal.pcbi.1008182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1008182</ArticleId><ArticleId IdType="pmc">PMC7518594</ArticleId><ArticleId IdType="pubmed">32931516</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J.S., Wang R.S., Leopold J.A., Loscalzo J. Network Determinants of Cardiovascular Calcification and Repositioned Drug Treatments. FASEB J. 2020;34:11087&#x2013;11100. doi: 10.1096/fj.202001062R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202001062R</ArticleId><ArticleId IdType="pmc">PMC7497212</ArticleId><ArticleId IdType="pubmed">32638415</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.  [(accessed on 9 May 2022)]; Available online:  https://www.covid19treatmentguidelines.nih.gov/</Citation></Reference><Reference><Citation>Wang M., Li A., Sekiya M., Beckmann N.D., Quan X., Schrode N., Fernando M.B., Yu A., Zhu L., Cao J., et al. Transformative Network Modeling of Multi-Omics Data Reveals Detailed Circuits, Key Regulators, and Potential Therapeutics for Alzheimer&#x2019;s Disease. Neuron. 2021;109:257&#x2013;272.e14. doi: 10.1016/j.neuron.2020.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.11.002</ArticleId><ArticleId IdType="pmc">PMC7855384</ArticleId><ArticleId IdType="pubmed">33238137</ArticleId></ArticleIdList></Reference><Reference><Citation>Barupal D.K., Gao B., Budczies J., Phinney B.S., Perroud B., Denkert C., Fiehn O. Prioritization of Metabolic Genes as Novel Therapeutic Targets in Estrogen-Receptor Negative Breast Tumors Using Multi-Omics Data and Text Mining. Oncotarget. 2019;10:3894&#x2013;3909. doi: 10.18632/oncotarget.26995.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.26995</ArticleId><ArticleId IdType="pmc">PMC6570467</ArticleId><ArticleId IdType="pubmed">31231467</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirzakhani H., Litonjua A.A., McElrath T.F., O&#x2019;Connor G., Lee-Parritz A., Iverson R., MacOnes G., Strunk R.C., Bacharier L.B., Zeiger R., et al. Early Pregnancy Vitamin D Status and Risk of Preeclampsia. J. Clin. Investig. 2016;126:4702&#x2013;4715. doi: 10.1172/JCI89031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI89031</ArticleId><ArticleId IdType="pmc">PMC5127689</ArticleId><ArticleId IdType="pubmed">27841759</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlotter F., Halu A., Goto S., Blaser M.C., Body S.C., Lee L.H., Higashi H., Delaughter D.M., Hutcheson J.D., Vyas P., et al. Spatiotemporal Multi-Omics Mapping Generates a Molecular Atlas of the Aortic Valve and Reveals Networks Driving Disease. Circulation. 2018;138:377&#x2013;393. doi: 10.1161/CIRCULATIONAHA.117.032291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.117.032291</ArticleId><ArticleId IdType="pmc">PMC6160370</ArticleId><ArticleId IdType="pubmed">29588317</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Halu A., Decano J.L., Padi M., Liu Y.Y., Prasad R.B., Fadista J., Santolini M., Menche J., Weiss S.T., et al. Controllability in an Islet Specific Regulatory Network Identifies the Transcriptional Factor NFATC4, Which Regulates Type 2 Diabetes Associated Genes. NPJ Syst. Biol. Appl. 2018;4:1&#x2013;11. doi: 10.1038/s41540-018-0057-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41540-018-0057-0</ArticleId><ArticleId IdType="pmc">PMC6028434</ArticleId><ArticleId IdType="pubmed">29977601</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerum T.V., Aal&#xf8;kken T.M., Br&#xf8;nstad E., Aarli B., Ikdahl E., Lund K.M.A., Durheim M.T., Rodriguez J.R., Meltzer C., Tonby K., et al. Dyspnoea, Lung Function and CT Findings 3 Months after Hospital Admission for COVID-19. Eur. Respir. J. 2021;57:1. doi: 10.1183/13993003.03448-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03448-2020</ArticleId><ArticleId IdType="pmc">PMC7736755</ArticleId><ArticleId IdType="pubmed">33303540</ArticleId></ArticleIdList></Reference><Reference><Citation>Froidure A., Mahsouli A., Liistro G., de Greef J., Belkhir L., G&#xe9;rard L., Bertrand A., Koenig S., Pothen L., Yildiz H., et al. Integrative Respiratory Follow-up of Severe COVID-19 Reveals Common Functional and Lung Imaging Sequelae. Respir. Med. 2021;181:106383. doi: 10.1016/j.rmed.2021.106383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106383</ArticleId><ArticleId IdType="pmc">PMC8019490</ArticleId><ArticleId IdType="pubmed">33839588</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent Symptoms in Patients after Acute COVID-19. JAMA J. Am. Med. Assoc. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Mezlini A.M., Demir F., Fiume M., Tu Z., Brudno M., Haibe-Kains B., Goldenberg A. Similarity Network Fusion for Aggregating Data Types on a Genomic Scale. Nat. Methods. 2014;11:333&#x2013;337. doi: 10.1038/nmeth.2810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2810</ArticleId><ArticleId IdType="pubmed">24464287</ArticleId></ArticleIdList></Reference><Reference><Citation>Chierici M., Bussola N., Marcolini A., Francescatto M., Zandon&#xe0; A., Trastulla L., Agostinelli C., Jurman G., Furlanello C. Integrative Network Fusion: A Multi-Omics Approach in Molecular Profiling. Front. Oncol. 2020;10:1065. doi: 10.3389/fonc.2020.01065.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2020.01065</ArticleId><ArticleId IdType="pmc">PMC7340129</ArticleId><ArticleId IdType="pubmed">32714870</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>